“…Thus, an optimum balance between the more stable phase of HA and the more soluble b-TCP exists in BCP [2], whose bioactivity is controlled by an association of HA and b-TCP in adequate ratios [3,4]. For this reason, BCP is more efficient than HA alone for different applications [5] and BCP bioceramics are recommended for use as an alternative or additive to autogenous bone for orthopedic and dental applications [1,4]. Mixtures of ceramics with agarose, as natural biodegradable binder, have been recently performed in order to increase the flexibility of the ceramic component and to facilitate the biomaterial preparation in different pieces with the desired size and shape according to the needs of the patient [6,7].…”